TerminatedPhase 4

Ideal Time of Oxytocin Infusion During Cesarean Section

Stopped: PI left Loyola and Sub-I graduated.

United States68 participantsStarted 2017-09-13

Plain-language summary

This study will evaluate if the timing of oxytocin administration in cesarean deliveries will affect the amount of maternal blood loss. Half of participants will receive oxytocin after delivery of the fetal anterior shoulder and the other half will receive oxytocin after delivery of the placenta. We hypothesize that administering oxytocin after delivery of the shoulder, will result in less overall maternal blood loss.

Who can participate

Age range

18 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women undergoing cesarean section at Loyola Hospital * Women who read and speak the English and/or Spanish language * Women age 18 or older Exclusion Criteria: * Women who deliver vaginally * Gestation under 37 weeks and 0 days * Women with coagulopathies * Multiple gestation pregnancies * Antepartum hemorrhage for example abruption * Placental abnormalities for example previa, accreta

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Total blood loss

Timeframe: At the completion of the surgery when patient is transferred to recovery from the operating room

Trial details

NCT IDNCT03246919

SponsorLoyola University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-02-24

View on ClinicalTrials.gov More Blood Loss, Surgical trials